Press Releases about Nls Pharmaceutics Ltd WT
Via ACCESSWIRE
NLS Pharmaceutics to Participate in Upcoming Investor Conferences
January 11, 2023
Via ACCESSWIRE
NLS Pharmaceutics CEO Issues Letter to Shareholders
December 22, 2022
Via ACCESSWIRE
Via ACCESSWIRE
NLS Pharmaceutics Successfully Appeals Nasdaq Delisting Notice
November 14, 2022
Via ACCESSWIRE
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
From NLS Pharmaceutics AG
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NLS Pharmaceutics Ltd. Announces Closing of US$4.4 Million Registered Direct Offering
April 26, 2022
From NLS Pharmaceutics AG
Via AccessWire
Topics
Regulatory Compliance
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.